DB

Didier Branellec

AS Aventis Pharma S.A.: 3 patents #139 of 591Top 25%
CU Case Western Reserve University: 2 patents #368 of 1,377Top 30%
CE Centelion: 1 patents #7 of 13Top 55%
LL Licentia Group Limited: 1 patents #14 of 76Top 20%
LR Ludwig Institute For Cancer Research: 1 patents #339 of 611Top 60%
University of California: 1 patents #8,022 of 18,278Top 45%
📍 Chennevières-sur-Marne, FR: #7 of 74 inventorsTop 10%
Overall (All Time): #873,557 of 4,157,543Top 25%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
7193075 Sequences upstream of the CARP gene, vectors containing them and uses thereof Patrick Benoit, Bertrand Schwartz, Kenneth R. Chien, Ju Chen 2007-03-20
6793918 In vivo stimulation of angiogenic activity Berndt Enholm, Seppo Ylae-Herttuala, Ralf Pettersson, Erika Bergsten, Ulf Eriksson +2 more 2004-09-21
RE37933 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis Kenneth Walsh, Jeffrey M. Isner, Patrice Denefle 2002-12-10
6410011 Gene therapy for restenosis using an adenoviral vector Jean-Francois Dedieu, Patrice Denefle, Laurent Feldman, Michel Perricaudet, Philippe Gabriel Steg 2002-06-25
6121005 Polypeptides comprising domains of the GAX protein implicated in the repression of transcription and/or interaction with other proteins, corresponding nucleic acids, and their use Alain Fournier, Abderrahim Mahfoudi, Christophe Marcireau 2000-09-19
5851521 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis Kenneth Walsh, Jeffrey M. Isner, Patrice Denefle 1998-12-22